Correlation Between Bristol Myers and Teladoc Health

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Teladoc Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Teladoc Health into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Teladoc Health, you can compare the effects of market volatilities on Bristol Myers and Teladoc Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Teladoc Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Teladoc Health.

Diversification Opportunities for Bristol Myers and Teladoc Health

0.81

Correlation Coefficient

Bristol Myers  Teladoc Health

Very poor diversification

The 3 months correlation between Bristol and Teladoc is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Teladoc Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teladoc Health and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Teladoc Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teladoc Health has no effect on the direction of Bristol Myers i.e., Bristol Myers and Teladoc Health go up and down completely randomly.

Pair Corralation between Bristol Myers and Teladoc Health

Assuming the 90 days trading horizon Bristol Myers Squibb is expected to generate 0.54 times more return on investment than Teladoc Health. However, Bristol Myers Squibb is 1.85 times less risky than Teladoc Health. It trades about 0.02 of its potential returns per unit of risk. Teladoc Health is currently generating about -0.02 per unit of risk. If you would invest  32,462  in Bristol Myers Squibb on October 3, 2024 and sell it today you would earn a total of  3,130  from holding Bristol Myers Squibb or generate 9.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	82.78%
Values	Daily Returns

Bristol Myers Squibb  vs.  Teladoc Health

Bristol Myers Squibb

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bristol Myers sustained solid returns over the last few months and may actually be approaching a breakup point.

Teladoc Health

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Teladoc Health are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Teladoc Health sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bristol Myers and Teladoc Health

The main advantage of trading using opposite Bristol Myers and Teladoc Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Teladoc Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teladoc Health will offset losses from the drop in Teladoc Health's long position.

The idea behind Bristol Myers Squibb and Teladoc Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.